No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
- PMID: 32728733
- PMCID: PMC7454831
- DOI: 10.1093/rheumatology/keaa388
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
References
-
- News SIR The Italian Society of Rheumatology answers to patients about COVID-19 pandemic. https://www.reumatologia.it/cmsx.asp?IDPg=1087 (25 June 2020, date last accessed).
-
- Chen H, Wang F, Zhang P. et al.Management of cytokine release syndrome related to CAR-T cell therapy. Front Med 2019;13:610–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
